Teri L. Lawver

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Sam Martin, attorney-in-fact for Teri Lawver
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Teri L. Lawver:

Company Role Class Num Shares Value Price $ Report Date Ownership
DEXCOM INC EVP Chief Commercial Officer Common Stock 66,641 $8,957,263 $134.41 12 Mar 2024 Direct
Celldex Therapeutics, Inc. SVP & Chief Commercial Officer ISO (right to buy) 100,000 10 Nov 2025 Direct
Altimmune, Inc. Director Stock Options (option to buy) 48,800 25 Sep 2025 Direct

Insider Reports Filed by Teri L. Lawver

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLDX Celldex Therapeutics, Inc. 10 Nov 2025 1 $0 4 SVP & Chief Commercial Officer 12 Nov 2025, 16:12
CLDX Celldex Therapeutics, Inc. 10 Nov 2025 0 $0 3 SVP & Chief Commercial Officer 12 Nov 2025, 16:05
ALT Altimmune, Inc. 25 Sep 2025 1 $0 4 Director 29 Sep 2025, 16:19
ALT Altimmune, Inc. 24 Feb 2025 1 $0 4 Director 26 Feb 2025, 18:47
ALT Altimmune, Inc. 24 Feb 2025 0 $0 3 Director 26 Feb 2025, 18:46
DXCM DEXCOM INC 12 Mar 2024 1 -$640,333 4 EVP Chief Commercial Officer 14 Mar 2024, 17:39
DXCM DEXCOM INC 08 Mar 2024 1 $0 4 EVP Chief Commercial Officer 11 Mar 2024, 18:31
DXCM DEXCOM INC 08 Mar 2023 1 +$45.35 4 EVP Chief Commercial Officer 10 Mar 2023, 15:00
DXCM DEXCOM INC 09 Jan 2023 0 $0 3 EVP Chief Commercial Officer 09 Jan 2023, 15:35